1 Medzhitov R, "Toll-like receptors and innate immunity" 1 : 135-145, 2001
2 Kassinen A, "The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects" 133 : 24-33, 2007
3 Ohman L, "T-cell activation in patients with irritable bowel syndrome" 104 : 1205-1212, 2009
4 Cremon C, "Mucosal immune activation in irritable bowel syndrome: gender dependence and association with digestive symptoms" 104 : 392-400, 2009
5 Chey WD, "Irritable bowel syndrome: a clinical review" 313 : 949-958, 2015
6 Camilleri M, "Intestinal permeability and irritable bowel syndrome" 19 : 545-552, 2007
7 Longstreth GF, "Functional bowel disorders" 130 : 1480-1491, 2006
8 Oscar Rodríguez-Fandiño, "From Cytokines to Toll-Like Receptors and Beyond - Current Knowledge and Future Research Needs in Irritable Bowel Syndrome" 대한소화기 기능성질환∙운동학회 16 (16): 363-373, 2010
9 Ratnakar Shukla, "Expression of Toll-like Receptors, Pro-, and Anti-inflammatory Cytokines in Relation to Gut Microbiota in Irritable Bowel Syndrome: The Evidence for Its Micro-organic Basis" 대한소화기 기능성질환∙운동학회 24 (24): 628-642, 2018
10 Barbara G, "A role for inflammation in irritable bowel syndrome" 51 (51): i41-i44, 2002